Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection

Vaccine

Volumn 23, Issue 14, 2005, Pages 1680-1685

  Palendira, Umaimainthan ^a,b   Spratt, Joanne M ^a   Britton, Warwick J ^a,c   Triccas, James A ^a,c  

^a CENTENARY INSTITUTE   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Recombinant BCG; Secreted antigens; Tuberculosis; Vaccine

Indexed keywords

BCG VACCINE; HYBRID PROTEIN;

AEROSOL; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; IMMUNIZATION; IMMUNOGENICITY; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUBERCULOSIS;

EID: 13444274693     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.10.007     Document Type: Article

References (23)

1. E.L. Corbett, C.J. Watt, N. Walker, D. Maher, B.G. Williams, and M.C. Raviglione The growing burden of tuberculosis: global trends and interactions with the HIV epidemic Arch Intern Med 63 2003 1009 1021
2. P.E. Fine Variation in protection by BCG: implications of and for heterologous immunity Lancet 346 1995 1339 1345
3. C.K. Stover, V.F. de la Cruz, T.R. Fuerst, J.E. Burlein, L.A. Benson, and L.T. Bennett New use of BCG for recombinant vaccines Nature 351 1991 456 460
4. M.A. Behr, M.A. Wilson, W.P. Gill, H. Salamon, G.K. Schoolnik, and S. Rane Comparative genomics of BCG vaccines by whole-genome DNA microarray Science 284 1999 1520 1523
5. P. Andersen, A.B. Andersen, A.L. Sorensen, and S. Nagai Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice J Immunol 154 1995 3359 3372
6. A.S. Mustafa, H.A. Amoudy, H.G. Wiker, A.T. Abal, P. Ravn, and F. Oftung Comparison of antigen-specific T cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis Scand J Immunol 48 1998 535 543
7. J.M. Pollock, and P. Andersen Predominant recognition of the ESAT-6 protein in the first phase of interferon with Mycobacterium bovis in cattle Infect Immun 65 1997 2587 2592
8. M.A. Horwitz, G. Harth, B.J. Dillon, and S. Maslesa-Galic Recombinant Bacillus Calmette-Guérin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model PNAS 97 2000 13853 13858
9. P.W. Roche, J.A. Triccas, D.T. Avery, T. Fifis, H. Billman-Jacobe, and W.J. Britton Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guérin from infection with Mycobacterium tuberculosis J Infect Dis 170 1994 1326 1330
10. A. Weinrich Olsen, L.A. van Pinxteren, L. Meng Okkels, P. Birk Rasmussen, and P. Andersen Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6 Infect Immun 69 2001 2773 2778
11. S.G. Tangye, B.C. van de Weerdt, D.T. Avery, and P.D. Hodgkin CD84 is up-regulated on a major population of human memory B cells and recruits the SH2 domain containing proteins SAP and EAT-2 Eur J Immunol 32 2002 1640 1649
12. M.A. O'Donnell, A. Aldovini, R.B. Duda, H. Yang, A. Szilvasi, and R.A. Young Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes Infect Immun 62 1994 2508 2514
13. V. Pelicic, M. Jackson, J.M. Reyrat, W.R. Jacobs Jr., B. Gicquel, and C. Guilhot Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis PNAS 94 1998 10955 10960
14. U. Palendira, A.T. Kamath, C.G. Feng, E. Martin, P.J. Chaplin, and J.A. Triccas Coexpression of interleukin-12 chains by a self-splicing vector increases the protective cellular immune response of DNA and Mycobacterium bovis BCG vaccines against Mycobacterium tuberculosis Infect Immun 70 2002 1949 1956
15. L. Brandt, M. Elhay, I. Rosenkrands, E.B. Lindblad, and P. Andersen ESAT-6 subunit vaccination against Mycobacterium tuberculosis Infect Immun 68 2000 791 795
16. A.T. Kamath, C.G. Feng, M. Macdonald, H. Briscoe, and W.J. Britton Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis Infect Immun 67 1999 1702 1707
17. A.S. Pym, P. Brodin, L. Majlessi, R. Brosch, C. Demangel, and A. Williams Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis Nat Med 9 2003 533 539
18. R.M. Kedl, J.W. Kappler, and P. Marrack Epitope dominance, competition and T cell affinity maturation Curr Opin Immunol 15 2003 120 127
19. A.W. Olsen, P.R. Hansen, A. Holm, and P. Andersen Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen Eur J Immunol 30 2000 1724 1732
20. L.Y. Armitige, C. Jagannath, A.R. Wanger, and S.J. Norris Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages Infect Immun 68 2000 767 778
21. M.A. Horwitz, and G. Harth A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis Infect Immun 71 2003 1672 1679
22. T. Hsu, S.M. Hingley-Wilson, B. Chen, M. Chen, A.Z. Dai, and P.M. Morin The primary mechanism of attenuation of bacillus Calmette-Guérin is a loss of secreted lytic function required for invasion of lung interstitial tissue PNAS 100 2003 12420 12425
23. L. Bao, W. Chen, H. Zhang, and X. Wang Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis Infect Immun 71 2003 1656 1661